Ethical Considerations in Pharmacogenomics

作者: Anjana Munshi , Yog Raj Ahuja

DOI: 10.1007/978-81-322-1184-6_8

关键词:

摘要: The science of pharmacogenomics holds the promise to change way in which clinical drug trials are conducted as well prescription drugs on a routine basis. However, there number ethical and regulatory challenges such subject recruitment, privacy, sample collection storage, confidentiality, major concern for conducting genomics-based studies. Stratification study subjects into subgroups basis genotype is another problem designing studies might lead selection biases. This could also spurious interpretations statistical analysis. Subtype stratification can result scientific data analysis because penetrance. variable degree clinically relevant phenotypic expression genetic variation false positives. Moreover, discrimination by job providers insurance firms other issues legal considerations need be answered. development orphan phenotype. If new molecule being developed only subpopulation patients, then distributive justice fairness accept considered. No doubt emerging boon medical fraternity; however, translation practice requires frame address along with incentives overcome these roadblocks.

参考文章(72)
Neil Risch, Esteban Burchard, Elad Ziv, Hua Tang, Categorization of humans in biomedical research: genes, race and disease Genome Biology. ,vol. 3, pp. 1- 12 ,(2002) , 10.1186/GB-2002-3-7-COMMENT2007
Choong-Chor Chang, Chun-Lai Too, Shahnaz Murad, Suraiya Hani Hussein, Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens–Johnson syndrome in the multi-ethnic Malaysian population International Journal of Dermatology. ,vol. 50, pp. 221- 224 ,(2011) , 10.1111/J.1365-4632.2010.04745.X
Lon R Cardon, Ramana M Idury, Timothy JR Harris, John S Witte, Robert C Elston, None, Testing drug response in the presence of genetic information: sampling issues for clinical trials. Pharmacogenetics. ,vol. 10, pp. 503- 510 ,(2000) , 10.1097/00008571-200008000-00003
Eleanor J. Murphy, Priya Wickramaratne, Myrna M. Weissman, Racial and ethnic differences in willingness to participate in psychiatric genetic research. Psychiatric Genetics. ,vol. 19, pp. 186- 194 ,(2009) , 10.1097/YPG.0B013E32832CEC89
Amalia M. Issa, Ethical perspectives on pharmacogenomic profiling in the drug development process. Nature Reviews Drug Discovery. ,vol. 1, pp. 300- 308 ,(2002) , 10.1038/NRD771
Denis M Grant, Nicola C Hughes, Susan A Janezic, Geoffrey H Goodfellow, Hillary J Chen, Andrea Gaedigk, Violeta L Yu, Ranbir Grewal, Human acetyltransferase polymorphisms Mutation Research. ,vol. 376, pp. 61- 70 ,(1997) , 10.1016/S0027-5107(97)00026-2
Lea Harty, Keith Johnson, Aidan Power, Race and ethnicity in the era of emerging pharmacogenomics. The Journal of Clinical Pharmacology. ,vol. 46, pp. 405- 407 ,(2006) , 10.1177/0091270005286028
Margie L. Clapper, Genetic polymorphism and cancer risk. Current Oncology Reports. ,vol. 2, pp. 251- 256 ,(2000) , 10.1007/S11912-000-0075-Z
Benjamin R. Bates, John A. Lynch, Jennifer L. Bevan, Celeste M. Condit, Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research. Social Science & Medicine. ,vol. 60, pp. 331- 344 ,(2005) , 10.1016/J.SOCSCIMED.2004.05.012